Sanjeev Dhara1, Ernest E Moore2, Michael B Yaffe3, Hunter B Moore2, Christopher D Barrett3. 1. University of Chicago School of Medicine, Chicago, IL. 2. Department of Surgery, University of Colorado Denver, Denver, CO. 3. Koch Institute for Integrative Cancer Research, Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, MA.
Abstract
PURPOSE OF REVIEW: The purpose of this review is to briefly outline the current state of hemorrhage control and resuscitation in trauma patients with a specific focus on the role viscoelastic assays have in this complex management, to include indications for use across all phases of care in the injured patient. RECENT FINDINGS: Viscoelastic assay use to guide blood-product resuscitation in bleeding trauma patients can reduce mortality by up to 50%. Viscoelastic assays also reduce total blood products transfused, reduce ICU length of stay, and reduce costs. There are a large number of observational and retrospective studies evaluating viscoelastic assay use in the initial trauma resuscitation, but only one randomized control trial. There is a paucity of data evaluating use of viscoelastic assays in the operating room, post-operatively, and during ICU management in trauma patients, rendering their use in these settings extrapolative/speculative based on theory and data from other surgical disciplines and settings. SUMMARY: Both hypocoagulable and hypercoagulable states exist in trauma patients, and better indicate what therapy may be most appropriate. Further study is needed, particularly in the operating room and post-operative/ICU settings in trauma patients.
PURPOSE OF REVIEW: The purpose of this review is to briefly outline the current state of hemorrhage control and resuscitation in trauma patients with a specific focus on the role viscoelastic assays have in this complex management, to include indications for use across all phases of care in the injured patient. RECENT FINDINGS: Viscoelastic assay use to guide blood-product resuscitation in bleeding trauma patients can reduce mortality by up to 50%. Viscoelastic assays also reduce total blood products transfused, reduce ICU length of stay, and reduce costs. There are a large number of observational and retrospective studies evaluating viscoelastic assay use in the initial trauma resuscitation, but only one randomized control trial. There is a paucity of data evaluating use of viscoelastic assays in the operating room, post-operatively, and during ICU management in trauma patients, rendering their use in these settings extrapolative/speculative based on theory and data from other surgical disciplines and settings. SUMMARY: Both hypocoagulable and hypercoagulable states exist in trauma patients, and better indicate what therapy may be most appropriate. Further study is needed, particularly in the operating room and post-operative/ICU settings in trauma patients.
Authors: Philip C Spinella; Heather F Pidcoke; Geir Strandenes; Tor Hervig; Andrew Fisher; Donald Jenkins; Mark Yazer; James Stubbs; Alan Murdock; Anne Sailliol; Paul M Ness; Andrew P Cap Journal: Transfusion Date: 2016-04 Impact factor: 3.157
Authors: A Britton Christmas; Ashley K Wilson; Glen A Franklin; Frank B Miller; J David Richardson; Jorge L Rodriguez Journal: Am Surg Date: 2005-12 Impact factor: 0.688
Authors: Jessica C Cardenas; Nena Matijevic; Lisa A Baer; John B Holcomb; Bryan A Cotton; Charles E Wade Journal: Shock Date: 2014-06 Impact factor: 3.454
Authors: Manuel Burggraf; Christina Polan; Heinz-Lothar Meyer; Roman Maximilian Müller; Felix Reinecke; Marcel Dudda; Max Daniel Kauther Journal: Biomed Res Int Date: 2020-12-30 Impact factor: 3.411